Mount Sinai Department of Medicine

On October 30, 2024, we proudly celebrated the recipients of the Cullman Family Award for Excellence in Provider Communication at Mount Sinai Health System. This award recognizes physicians and advanced practice providers who rank in the top 5% nationwide for outstanding communication, based on the 2023 Press Ganey patient experience assessments. Several of our exceptional care providers in the Department of Medicine were honored for their dedication to clear, compassionate communication with patients. We are incredibly proud of their commitment to providing the highest quality care. #HealthcareExcellence #PatientExperience #MountSinai #MedicalLeadership

Valerie Orellana, RN, discusses the work Mount Sinai has done with STRIVE, a leader in workforce development for people facing systemic barriers to employment. https://lnkd.in/eCNQDz4S

Joshua Safer, MD, explains the individualized approach to gender-affirming care for trans youth. “Gender-affirming care isn’t one protocol—it’s tailored to each person. Most trans individuals seeking medical interventions start with their primary care provider or a supportive clinic. For young adults, the medical community looks for thoughtful, long-term awareness of their gender identity, often explored over years, sometimes with therapists.” Learn more: https://bit.ly/4fFOWCK

What an honor to be included in this group. Definitely a reflection of all the effort during the past decade, excellent coworkers, trainees and collaborators. More to come... Mount Sinai Department of Medicine Icahn School of Medicine at Mount Sinai

Scott Lorin, MD, discusses his research regarding the utility of expanding a C. auris admission screening protocol at an acute care hospital in order to screen all patients presenting from any skilled nursing facility. https://lnkd.in/eC_43c8m

Mount Sinai Health System has been awarded nearly $7 million from the National Institutes of Health (NIH) to lead a New York coalition of the NIH’s All of Us Research Program. Approximately $1.3 million of this award was provided through the NIH Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, to increase efforts to recruit participants who use or have used substances, particularly opioids. All of Us is a historic effort to gather data from 1 million or more people in the United States, with the goal of accelerating health research and medical breakthroughs and enabling individualized prevention, treatment, and care. “This multi-institutional effort will fill a gap to significantly increase recruitment of participants in an area of the country with rich diversity,” said Principal Investigator Monica Kraft, MD. Read more: https://mshs.co/40YzcGI

Mount Sinai Health System launches the Center of Excellence for Gynecologic Cancer, part of The Tisch Cancer Institute. Led by Stephanie Blank, MD and Dmitriy Zamarin, MD PhD, this center offers comprehensive care, from diagnosis to innovative treatments, including clinical trials for immunotherapies and targeted therapies. With a focus on individualized care and supporting women through all stages of treatment, we’re setting new benchmarks in gynecologic cancer care. Learn more: https://bit.ly/48XBdVi #GynecologicCancer #WomensHealth #CancerCare #MountSinai #InnovationInHealthcare

Johanna Contreras, MD, discusses walking distance and speed, and what people need to know about the benefits of prioritizing each one. https://lnkd.in/gHcp9CWh

On Pancreatic Cancer Awareness Day, Department of Surgery at Mount Sinai's Dr. Cohen surgery and Dr. James O. Park, MD, FACS share their expertise on the fight against this challenging disease. From the importance of early detection to advancements in surgical care, they highlight how our team is pushing boundaries to provide hope and better outcomes for patients. Together, we can raise awareness, drive progress, and make a difference. Mount Sinai Health System The Mount Sinai Hospital #PancreaticCancerAwareness #MountSinaiSurgery #WeFindaWay #AdvancingCare

Mount Sinai researchers have made a significant breakthrough by uncovering how targeting gut-associated lymphoid tissue (GALT) plays a critical role in managing chronic inflammation in UC and Crohn’s disease. This discovery, published in Science Immunology, sheds light on the role of the integrin receptor α4β7 on white blood cells, including dendritic cells and T and B lymphocytes, in driving inflammation. “Our latest research helps us develop biomarkers based on real biology, leading to a better understanding of how individual patients respond to IBD treatments,” explains Dr. Saurabh Mehandru, who has led a mucosal immunology lab at Mount Sinai for over a decade. Learn more: https://bit.ly/4fVgHao Mount Sinai Department of Medicine